Literature DB >> 11283530

Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy.

Y Sugawara1, J Yamamoto, S Yamasaki, K Shimada, T Kosuge, M Makuuchi.   

Abstract

BACKGROUND: The effect of the time interval between colorectal and liver resection for metastatic lesions on the patient's survival remains controversial. Pretreatment classification for predicting the prognosis of this disease has not yet been reported.
METHODS: Nine clinical factors revealed by preoperative examinations, intraoperative screening before liver resection, and resection margin were examined in 304 patients who underwent hepatic resections for metastatic colorectal carcinoma. The patients were divided according to the timing of hepatectomy and both tumor number and maximum diameter to devise a staging system.
RESULTS: Tumor number and maximum tumor size were significant prognostic factors in the metachronous hepatectomy group, and resection margin was significant in the synchronous group. The following staging system was proposed: stage I, n < or = 3 and diameter < 5 cm in the metachronous hepatectomy group (n = 86); stage II, n < or = 3 and diameter > or = 5 cm in the metachronous hepatectomy group (n = 46); and stage III, n > or = 4 and diameter > 5 cm in the metachronous group and the synchronous hepatectomy group (n = 144).
CONCLUSIONS: The current study revealed that the factors that influenced the patient's prognosis were different between the synchronous and metachronous groups. It may be useful to develop a staging system that considers this difference.

Entities:  

Mesh:

Year:  2001        PMID: 11283530     DOI: 10.1067/msy.2001.112001

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

Review 1.  Treatment for multiple bilobar liver metastases of colorectal cancer.

Authors:  Hiroshi Shimada; Kuniya Tanaka; Kenichi Matsuo; Shinji Togo
Journal:  Langenbecks Arch Surg       Date:  2005-12-01       Impact factor: 3.445

2.  Utility of preoperative imaging in evaluating colorectal liver metastases declines over time.

Authors:  Simon Yang; Sermsak Hongjinda; Sherif S Hanna; Steven Gallinger; Alice C Wei; Alex Kiss; Calvin Law
Journal:  HPB (Oxford)       Date:  2010-09-02       Impact factor: 3.647

3.  Proposal of a new and simple staging system of colorectal liver metastasis.

Authors:  Ikuo Nagashima; Tadahiro Takada; Hirokazu Nagawa; Tetsuichiro Muto; Kota Okinaga
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

4.  Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors.

Authors:  Ikuo Nagashima; Tadahiro Takada; Miki Adachi; Hirokazu Nagawa; Tetsuichiro Muto; Kota Okinaga
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

5.  Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases.

Authors:  Jin-Hwang Liu; Yao-Yu Hsieh; Wei-Shone Chen; Yen-Ning Hsu; Gar-Yang Chau; Hao-Wei Teng; Kuang-Liang King; Tzu-Chen Lin; Chen-Hwai Tzeng; Jen-Kou Lin
Journal:  Int J Colorectal Dis       Date:  2010-06-24       Impact factor: 2.571

6.  Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome.

Authors:  Adriano Tocchi; Gianluca Mazzoni; Stefania Brozzetti; Michelangelo Miccini; Diletta Cassini; Elia Bettelli
Journal:  Int J Colorectal Dis       Date:  2004-04-22       Impact factor: 2.571

7.  Impact of neoadjuvant chemotherapy with FOLFOX/FOLFIRI on disease-free and overall survival of patients with colorectal metastases.

Authors:  Sarah Y Boostrom; David M Nagorney; John H Donohue; Scott Harmsen; Kristine Thomsen; Florencia Que; Michael Kendrick; Kaye M Reid-Lombardo
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

8.  Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases.

Authors:  Peter J Allen; Nancy Kemeny; William Jarnagin; Ronald DeMatteo; Leslie Blumgart; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

9.  Survival after hepatic resection of colorectal cancer metastases: a national experience.

Authors:  Douglas J Robertson; Therese A Stukel; Daniel J Gottlieb; Jason M Sutherland; Elliott S Fisher
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

10.  Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors.

Authors:  Gena P Kanas; Aliki Taylor; John N Primrose; Wendy J Langeberg; Michael A Kelsh; Fionna S Mowat; Dominik D Alexander; Michael A Choti; Graeme Poston
Journal:  Clin Epidemiol       Date:  2012-11-07       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.